Medi-Cal Update

Obstetrics | April 2017 | Bulletin 514

Print Medi-Cal Update
 

1. Get the Latest Medi-Cal News: Subscribe to MCSS Today

MCSS Logo

The Medi-Cal Subscription Service (MCSS) is a free service that keeps you up-to-date on the latest Medi-Cal news. Subscribers receive subject-specific emails for urgent announcements and other updates shortly, after posting on the Medi-Cal website.

Subscribing is simple and free!

  1. Go to the MCSS Subscriber Form
  2. Enter your email address and ZIP code
  3. Customize your subscription by selecting subject areas for NewsFlash announcements, Medi-Cal Update bulletins and/or System Status Alerts

After submitting the form, a welcome email will be sent to the provided email address. If you are unable to locate the welcome email in your inbox, check your junk email folder.

For more information about MCSS, please visit the MCSS Help page.

Print Article | Return to Top
 

2. Update: DHCS Fiscal Intermediary Name Change

Effective immediately, providers may notice that the Department of Health Care Services (DHCS) Fiscal Intermediary (FI) for the Medi-Cal program, formerly Xerox State Healthcare, LLC (Xerox), is operating under a new company name, “Conduent.” Providers may also see the Conduent logo on some items.

Operations and interactions with providers are not impacted by this FI name change.

Providers may see this name change in items such as:

  • NewsFlash articles and Medi-Cal Update bulletins
  • Medi-Cal website (www.medi-cal.ca.gov)
  • Forms and User Guides
  • Provider Manuals
  • Medi-Cal Learning Portal (MLP)
  • Presentations at Provider Training Seminars
  • Provider Letters, such as Erroneous Payment Corrections (EPCs)
  • Additional hard copy correspondence
  • Emails with an “@conduent.com” address rather than an “@xerox.com” address
  • References to the Conduent name when researching mailing addresses or published telephone numbers
Conduent logo

There are no changes in the telephone numbers used by providers, including the Telephone Service Center (TSC) number (1-800-541-5555), as a result of this name change. The mailing addresses used by providers to conduct business with DHCS and the FI will remain the same.

Medi-Cal providers are strongly encouraged to subscribe to the Medi-Cal Subscription Service (MCSS) to receive notifications related to Medi-Cal Update bulletins, NewsFlash articles, and System Status Alerts. Providers may sign up for MCSS by visiting http://www.medi-cal.ca.gov and completing the MCSS Subscriber Form. For more information about Conduent, visit https://www.conduent.com.

Print Article | Return to Top
 

3. Billing Policy Clarifications for End of Life Option Act Services

Beginning May 1, 2017, the billing policy for End of Life Option Act (ELOA) services and aid-in-dying drugs has been clarified as follows:

 
HCPCS Code ICD-10-CM Diagnosis Codes
J7999 Z76.89
J8499 Z76.89
S0257 Z01.89, Z76.89

Additionally, the provider manual has been updated to reflect billing instructions regarding valid unit of measurement qualifiers. Billing examples for CMS-1500 and UB-04 forms have also been updated to reflect these instructions.

These updates are effective retroactively for dates of service on or after June 9, 2016.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
AIDS Waiver Program
Audiology and Hearing Aids
Chronic Dialysis Clinics
Community-Based Services
Durable Medical Equipment
Heroin Detoxification
Home Health Agencies/Home and Hospice Care Program
Medical Transportation
Obstetrics
Orthotics and Prosthetics
Rehabilitation Clinics
Therapies
Vision Care
medi non hcp (2)
Clinics and Hospitals eloa ub (6–11); medi non hcp (2)
General Medicine
Pharmacy
Psychological Services
eloa (7, 9, 11–14); eloa cms (5–11); medi non hcp (2)
Print Article | Return to Top
 

4. SSN Removal Initiative to Replace HIC Number on Medicare Cards

The Medicare Access and CHIP Reauthorization Act of 2015 requires Centers for Medicare & Medicaid Services (CMS) to remove Social Security Numbers (SSNs) from all Medicare cards by April 2019. A new Medicare Beneficiary Identifier (MBI) will replace the SSN-based Health Insurance Claim (HIC) number on new Medicare cards and will be used for transactions such as billing, eligibility status and claim status.

A transition period will allow providers to use either the HIC number or the MBI. The transition will begin no earlier than April 1, 2018, and run through December 31, 2019.

CMS currently uses SSN-based HIC numbers to identify Medicare recipients and have used HIC numbers with state Medicaid agencies, health care providers and health plans. Under the new system, CMS will assign a new MBI and send a new Medicare card for each recipient enrolled in Medicare. The MBI should be protected as Personally Identifiable Information (PII).

Additional resources can be found on the Providers and Health & drug plans Web pages of the CMS website.

Additional information regarding this transition will be announced in a future Medi-Cal Update.

Print Article | Return to Top
 

5. Assembly Bill 97 Ten Percent Reduction Removed from Pharmacy Claims

On February 1, 2016, the Centers for Medicare & Medicaid Services (CMS) published a final rule on covered outpatient drugs. The rule requires Medi-Cal to move to an Average Acquisition Cost (AAC) reimbursement model effective April 1, 2017. Welfare and Institutions Code (W&I Code) 14105.45 states that once an AAC model is adopted by the state, payment reductions pursuant to W&I Code 14105.192 no longer apply if budget reduction targets are deemed to be met. Therefore, for claims with dates of service on or after April 1, 2017, the 10 percent reimbursement reductions required by Assembly Bill (AB) 97 will no longer be applied to pharmacy billed drug products.

Provider Manual(s) Page(s) Updated
Pharmacy reimbursement (1)
Print Article | Return to Top
 

6. Authorized Drug Manufacturer Labeler Codes Update

The Drugs: Contract Drugs List Part 5 – Authorized Drug Manufacturer Labeler Codes section has been updated as follows.

Additions, effective April 1, 2017
NDC Labeler Code Contracting Company's Name
13517 E5 PHARMA, LLC
51267 OREXIGEN THERAPEUTICS, INC.
63646 TOLMAR, INC.
69051 PROFOUNDA, INC.
69639 HELSINN THERAPEUTICS (U.S.), INC.
69660 CLOVIS ONCOLOGY, INC.
70000 CARDINAL HEALTH 110, LLC. DBA LEADER
70688 KASTLE THERAPEUTICS, INC
70710 ZYDUS PHARMACEUTICALS (USA) INC.
Terminations, effective April 1, 2017
NDC Labeler Code Contracting Company's Name
66593 VIRO PHARMA, INC.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Adult Day Health Care Centers
AIDS Waiver Program
Chronic Dialysis Clinics
Clinics and Hospitals
Expanded Access to Primary Care Program
General Medicine
Heroin Detoxification
Home Health Agencies/Home and Community-Based Services
Hospice Care Program
Multipurpose Senior Services Program
Obstetrics
Pharmacy
Rehabilitation Clinics
drugs cdl p5 (6, 11, 14, 16, 18, 19)
Print Article | Return to Top
 

7. Medi-Cal List of Contract Drugs

The following provider manual section(s) have been updated: Drugs: Contract Drugs List Part 1 – Prescription Drugs, Drugs: Contract Drugs List Part 2 – Over-the-Counter Drugs and Drugs: Contract Drugs List Part 4 – Therapeutic Classifications.

A summary of drugs that have been changed is shown below. For additional information, click on the link to the manual section and scroll to the page indicated or use the find feature to search for the particular drug.

Changed Drug(s)
Effective Date Drug Summary of Changes Page(s) Updated
February, 6, 2017 MARAVIROC Restriction changed, restriction added, strength added drugs cdl p1b (61)
March 1, 2017 ACETOHEXAMIDE Note added drugs cdl p1a (2)
March 1, 2017 ALUMINUM CARBONATE GEL, BASIC Note added drugs cdl p2 (2)
March 1, 2017 AMPHOTERICIN B Note added drugs cdl p1a (12)
March 1, 2017 AMPRENAVIR Note added drugs cdl p1a (13)
March 1, 2017 AUROTHIOGLUCOSE Note added drugs cdl p1a (18)
March 1, 2017 BROMODIPHENHYDRAMINE HCL WITH CODEINE Note added drugs cdl p1a (25)
March 1, 2017 BROMPHENIRAMINE MALEATE WITH PHENYLPROPANOLAMINE HCL AND CODEINE Note added drugs cdl p1a (25)
March 1, 2017 CARBACHOL Note added drugs cdl p1a (30)
March 1, 2017 CARBENICILLIN Note added drugs cdl p1a (30)
March 1, 2017 CEFONICID SODIUM Note added drugs cdl p1a (33)
March 1, 2017 CERIVASTATIN SODIUM Note added drugs cdl p1a (34)
March 1, 2017 CHLORAL HYDRATE Note added drugs cdl p1a (35)
March 1, 2017 CHLOROTRIANISENE Note added drugs cdl p1a (35)
March 1, 2017 CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, POTASSIUM IODIDE AND CODEINE Note added drugs cdl p1a (35)
March 1, 2017 CHOLINE MAGNESIUM TRISALICYLATE Note added drugs cdl p1a (37)
March 1, 2017 CLOFAZIMINE Note added drugs cdl p1a (43)
March 1, 2017 COAL TAR Note added drugs cdl p2 (5)
March 1, 2017 CODEINE AND ASPIRIN Note added drugs cdl p1a (46)
March 1, 2017 CODEINE PHOSPHATE Note added drugs cdl p1a (46)
March 1, 2017 DEGARELIX Administration added drugs cdl p1a (53)
March 1, 2017 DEXAMETHASONE WITH NEOMYCIN Note added drugs cdl p1a (55)
March 1, 2017 DICALCIUM PHOSPHATE WITH OR WITHOUT
VITAMIN D
Note added drugs cdl p2 (6)
March 1, 2017 DIENESTROL CREAM (OR GENERIC EQUIVALENT) Note added drugs cdl p1a (59)
March 1, 2017 DIHYDROTACHYSTEROL Note added drugs cdl p1a (59)
March 1, 2017 DIPIVEFRIN HCL Note added drugs cdl p1a (61)
March 1, 2017 EPINEPHRINE Note added drugs cdl p1b (5)
March 1, 2017 EPINEPHRYL BORATE Note added drugs cdl p1b (5)
March 1, 2017 ERGOLOID MESYLATES Note added drugs cdl p1b (6)
March 1, 2017 ERGONOVINE MALEATE Note added drugs cdl p1b (6)
March 1, 2017 ERGOTAMINE TARTRATE WITH CAFFEINE AND PENTOBARBITAL SODIUM AND BELLADONNA ALKALOIDS Note added drugs cdl p1b (7)
March 1, 2017 ERYTHROMYCIN AND SULFISOXAZOLE Note added drugs cdl p1b (7)
March 1, 2017 ESTRADIOL CYPIONATE AND TESTOSTERONE CYPIONATE Note added drugs cdl p1b (9)
March 1, 2017 ETHINYL ESTRADIOL Note added drugs cdl p1b (11)
March 1, 2017 FURAZOLIDONE Note added drugs cdl p1b (25)
March 1, 2017 GEMTUZUMAB OZOGAMICIN Note added drugs cdl p1b (28)
March 1, 2017 GOLD SODIUM THIOMALATE Note added drugs cdl p1b (29)
March 1, 2017 GUANABENZ ACETATE Note added drugs cdl p1b (30)
March 1, 2017 HOMATROPINE Restriction added drugs cdl p1b (32)
March 1, 2017 HYDROCORTISONE WITH POLYMYXIN B Note added drugs cdl p1b (35)
March 1, 2017 IMATINIB MESYLATE Note added drugs cdl p1b (37)
March 1, 2017 KANAMYCIN SULFATE Note added drugs cdl p1b (47)
March 1, 2017 LEVAMISOLE HCL Note added drugs cdl p1b (52)
March 1, 2017 LEVODOPA Note added drugs cdl p1b (53)
March 1, 2017 LIQUOR CARBONIS DETERGENS Note added drugs cdl p2 (10)
March 1, 2017 MESORIDAZINE Note added drugs cdl p1b (64)
March 1, 2017 METIPRANOLOL HCL Note added drugs cdl p1b (68)
March 1, 2017 NALIDIXIC ACID Note added drugs cdl p1c (1)
March 1, 2017 NAPHAZOLINE HCL AND ANTAZOLINE PHOSPHATE Note added drugs cdl p2 (11)
March 1, 2017 NEOSTIGMINE BROMIDE Note added drugs cdl p1c (4)
March 1, 2017 NIACIN AND LOVASTATIN Note added drugs cdl p1c (4)
March 1, 2017 NIACIN AND SIMVASTATIN Note added drugs cdl p1c (5)
March 1, 2017 NICLOSAMIDE Note added drugs cdl p1c (5)
March 1, 2017 NORFLOXACIN Note added drugs cdl p1c (10)
March 1, 2017 OCTOXYNOL 9 CONTRACEPTIVE PRODUCTS Note added drugs cdl p2 (13, 14)
March 1, 2017 OPRELVEKIN Note added drugs cdl p1c (14)
March 1, 2017 OXYCODONE HCL WITH OXYCODONE TEREPHTHALATE AND ASPIRIN Note added drugs cdl p1c (18)
March 1, 2017 PERGOLIDE MESYLATE Note added drugs cdl p1c (24)
March 1, 2017 PHENYTOIN WITH PHENOBARBITAL Note added drugs cdl p1c (26)
March 1, 2017 PILOCARPINE WITH EPINEPHRINE Note added drugs cdl p1c (27)
March 1, 2017 PIPOBROMAN Note added drugs cdl p1c (28)
March 1, 2017 PLICAMYCIN Note added drugs cdl p1c (29)
March 1, 2017 POLYESTRADIOL PHOSPHATE Note added drugs cdl p1c (29)
March 1, 2017 PREDNISOLONE, NEOMYCIN, POLYMYXIN B Note added drugs cdl p1c (32)
March 1, 2017 PROCYCLIDINE Note added drugs cdl p1c (35)
March 1, 2017 PSEUDOEPHEDRINE HYDROCHLORIDE/
DIPHENHYDRAMINE HYDROCHLORIDE
Note added drugs cdl p2 (17)
March 1, 2017 ROSIGLITAZONE MALEATE Restriction added drugs cdl p1c (46)
March 1, 2017 ROSIGLITAZONE MALEATE/GLIMEPIRIDE Note added drugs cdl p1c (46)
March 1, 2017 ROSIGLITAZONE MALEATE/METFORMIN HCL Restriction added drugs cdl p1c (46)
March 1, 2017 SCOPOLAMINE HBr Note added drugs cdl p1d (2)
March 1, 2017 SIMVASTATIN/SITAGLIPTIN Note added drugs cdl p1d (3)
March 1, 2017 SULFATHIAZOLE, SULFACETAMIDE, SULFABENZAMIDE
(TRIPLE SULFA)
Note added drugs cdl p1d (8)
March 1, 2017 SULFINPYRAZONE Note added drugs cdl p1d (8)
March 1, 2017 SULFISOXAZOLE Note added drugs cdl p1d (8)
March 1, 2017 TESTOLACTONE Note added drugs cdl p1d (12)
March 1, 2017 THIABENDAZOLE Note added drugs cdl p1d (13)
March 1, 2017 THIAMINE HYDROCHLORIDE Strength removed drugs cdl p1d (13)
March 1, 2017 TRIMETREXATE GLUCURONATE Note added drugs cdl p1d (22)
March 1, 2017 TRIPROLIDINE HCL WITH PSEUDOEPHEDRINE HCL AND CODEINE Note added drugs cdl p1d (22)
March 1, 2017 URACIL MUSTARD Note added drugs cdl p1d (23)
March 1, 2017 ZALCITABINE Note added drugs cdl p1d (29)
June 1, 2017 PRASUGREL Restriction added drugs cdl p1c (31)
Print Article | Return to Top
 

8. Clinic Dispensing Limits Increased for Contraceptive Vaginal Ring and Patch

Effective for dates of service on or after January 1, 2017, in accordance with Senate Bill 999, the clinic dispensing policy for HCPCS codes J7303 (contraceptive supply, hormone containing vaginal ring, each) and J7304 (contraceptive supply, hormone containing patch, each) has been updated for the Medi-Cal and Family Planning Access, Care and Treatment (Family PACT) Programs as follows:

A Treatment Authorization Request (TAR) is required for an additional supply of vaginal rings or transdermal patches if they are requested within a three-month period of receiving a 12-month supply.

Though the clinic dispensing policy for J7303 and J7304 is effective January 1, 2017, providers should not bill with the updated quantity before May 1, 2017, or claims will be denied. Timeliness requirements will be overridden until notified.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Clinics and Hospitals
General Medicine
Obstetrics
fam planning (4, 8)
Family PACT ben grid (23); clinic (5, 6, 8, 10–12); drug (2); pharmacy (6, 9)
Print Article | Return to Top
 

9. CCS Service Code Groupings Update

The following codes will be added or end-dated to/from the California Children’s Services (CCS) Service Code Groupings (SCGs):

Added Codes:
Effective Date Code SCG
July 1, 2015 CPT-4 codes 80180, 86832, 86833 03
October 1, 2015 HCPCS codes C9444, C9446, C9447, J0153, J0887, J0888, J1439, J2274, J2704, J7336, J9120
CPT-4 codes 62304, 62305, 64486 – 64489, 76641, 76642, 77061 – 77063, 77085, 77086, 80163, 80165, 80300 – 80304, 80320 – 80377, 90630, 93702, 96127, 99490, 99497, 99498
01, 02, 03, 07
October 1, 2015 HCPCS codes A9606, C2624, C9442, G0472, G6001 – G6020, G6022 – G6025, G6027, G6028, J1071, J3121, J3145, J9267, J9301
CPT-4 codes 43180, 44381, 44384, 44401, 44402, 44404 – 44408, 45346, 45347, 45349, 45350, 45388 – 45390, 45393, 45398, 46601, 46607, 77306, 77307,
77316 – 77318, 77385 – 77387, 87623 – 87625, 87806, 88341, 88344, 88364, 88366, 88369, 88373, 88374, 88377, 89337, 91200, 93260, 93261, 93355, 93644, 93895, 99184
02
October 1, 2015 HCPCS codes Q4150 – Q4159
CPT-4 codes 20604, 20606, 20611, 20983,
21811 – 21813, 22510 – 22515, 22858, 27279
07
October 1, 2015 CPT-4 codes 66179, 66184, 92145 10
October 1, 2015 CPT-4 code 20606 12
April 1, 2016 HCPCS codes G0108, G0109
CPT-4 codes
97802 – 97804
01, 02, 03, 07

End-Dated Codes:
Effective Date Code SCG
October 1, 2015 HCPCS codes
G8629 – G8632, G8682, G8683, G8685, J0150, J1070, J1080, J2271, J2275, J3120, J7335, S0144
CPT-4 codes 29715, 72291, 72292, 74291, 76645, 76950, 80102, 80104, 80152, 80154, 80160, 80166, 80172, 80174, 80182, 80196, 82000, 82003, 82055, 82101, 82145, 82205, 82520, 82646, 82649, 82651, 82654, 82666, 82690, 82742, 82953, 82975, 82980, 83008, 83055, 83071, 83634, 83805, 83840, 83858, 83866, 83887, 83925, 84022, 84127, 87001,
87620 – 87622
01, 02, 03, 07
October 1, 2015 HCPCS code J9265
CPT-4 codes 21800, 44383, 44393, 44397, 45339, 45345, 45355, 45383, 45387, 77305, 77310, 77315, 77326 – 77328, 77403, 77404, 77406, 77408, 77409, 77411, 77413, 77414, 77416, 77418, 77421
02
October 1, 2015 CPT-4 codes 29020, 29025 07
October 1, 2015 CPT-4 codes J3140 01, 02, 03, 07, 09
October 1, 2015 CPT-4 codes 61334, 66165 10
October 1, 2015 HCPCS codes J0900, J1060
CPT-4 code 88349
01, 02, 03, 07, 12
Reminder:

SCG 02 includes all the codes in SCG 01, plus additional codes applicable only to SCG 02.

SCG 03 includes all the codes in SCG 01 and SCG 02, plus additional codes applicable only to SCG 03.

SCG 07 includes all the codes in SCG 01 plus additional codes applicable only to SCG 07.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Audiology and Hearing Aids
Chronic Dialysis Clinics
Clinics and Hospitals
Durable Medical Equipment
General Medicine
Home Health Agencies/Home and Community-Based Services
Inpatient Services
Local Educational Agency
Medical Transportation
Obstetrics
Orthotics and Prosthetics
Pharmacy
Psychological Services
Rehabilitation Clinics
Therapies
Vision Care
cal child ser (1–3, 5–17, 20, 23–29, 31)
Print Article | Return to Top
 

10. Eteplirsen Claims Require SAR for CCS and GHPP

Effective retroactively for dates of service on or after September 1, 2016, eteplirsen is added to the pharmacy list of drugs and nutritional products requiring a separate Service Authorization Request (SAR) for the California Children's Services (CCS) program and the Genetically Handicapped Persons Program (GHPP).

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Audiology and Hearing Aids
Chronic Dialysis Clinics
Clinics and Hospitals
Durable Medical Equipment
General Medicine
Home Health Agencies/Home and Community-Based Services
Inpatient Services
Local Educational Agency
Medical Transportation
Obstetrics
Orthotics and Prosthetics
Pharmacy
Psychological Services
Rehabilitation Clinics
Therapies
Vision Care
cal child sar (7); genetic (9)
Print Article | Return to Top
 

11. Resolved: Non-Home Health Claims Erroneously Denied with RAD Code 0076

A claim processing issue that caused non-Home Health claims to be erroneously denied with Remittance Advice Details (RAD) code 0076: The submitted documentation was not adequate has been resolved.

As a reminder, providers who are not required to record a revenue code on their claims should always leave blank the Revenue Code field (Box 42).

Affected claims will be re-processed by an Erroneous Payment Correction (EPC). No action is required of providers. Providers are encouraged to check the Medi-Cal website regularly for updates regarding this issue.

Print Article | Return to Top
 

12. Every Woman Counts Income Eligibility Guidelines Update

Effective April 1, 2017, through March 31, 2018, Every Woman Counts (EWC) providers are to use the following income guidelines when determining recipient eligibility for EWC. Providers should disregard all previous EWC income eligibility guideline charts.

EWC recipients must have a household income at or below 200 percent of the federal Health and Human Services (HHS) poverty guidelines. The HHS poverty guidelines are adjusted annually. “Gross household income” means income before taxes and other deductions.

EWC Income Eligibility Guidelines
200 Percent of the 2016 HHS Poverty Guidelines by Household Size
Effective April 1, 2017, through March 31, 2018

Number of Persons Living in Household Monthly Gross Household Income Annual Gross Household Income
1 $2,010 $24,120
2 $2,707 $32,480
3 $3,403 $40,840
4 $4,100 $49,200
5 $4,797 $57,560
6 $5,493 $65,920
7 $6,190 $74,280
8 $6,887 $82,640
For each additional person, add: $697 $8,360

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Clinics and Hospitals
General Medicine
Obstetrics
ev woman (9)
Print Article | Return to Top
 

13. PE for Pregnant Women Web Page Revised and New MC 311 Form Posted

Effective March 30, 2017, the Qualified Provider Application and Agreement for Participation in the Presumptive Eligibility for Pregnant Women (PE4PW) Program (MC 311) form has been updated on the Presumptive Eligibility for Pregnant Women Web page of the Medi-Cal website. This form is completed by providers applying to become PE4PW Qualified Providers or once enrolled, when requesting to add to their list of PE4PW clinic(s).

Instructions on completing the form are included with the MC 311 (version 12/16). Providers should review the provider requirements, submission checklist and notification overview when completing the form.

Note:

Providers will submit the form to Telephone Service Center using the address provided on the form. PE4PW providers are encouraged to review the PE4PW Web page’s Frequently Asked Questions (FAQs) and to visit the NewsFlash area of the Medi-Cal website for articles and materials related to the PE4PW program.

The PE4PW Web page has three new headings. “Application Forms” has changed to “Paper Process Forms (usable until 9/30/17).” The new MC 311 form is posted under the new “Qualified Provider Enrollment Form” heading. Lastly, a “User Guide” heading has been added to accommodate the new Presumptive Eligibility for Pregnant Women (PE4PW) Application Web Portal User Guide.

Print Article | Return to Top
 

14. New Presumptive Eligibility for Pregnant Women User Guide

The Presumptive Eligibility for Pregnant Women (PE4PW) Application Web Portal User Guide is now available on the Medi-Cal website. The user guide provides instructions for accessing and performing a PE4PW Web Portal transaction.

Providers may download the user guide and access additional PE4PW Program information on the Presumptive Eligibility for Pregnant Women Web page of the Medi-Cal website.

Print Article | Return to Top
 

15. Private Duty Nursing for Children and Adolescents Under EPSDT Detailed

Private duty nursing (PDN) for children and adolescents under 21 years of age is available under the Medi-Cal Early and Periodic Screening, Diagnostic and Treatment (EPSDT) benefit. To be covered under EPSDT, PDN must be medically necessary to correct or make more tolerable the child's or adolescent's physical or mental condition. The determination of medical necessity is made case by case, taking into account the needs of the individual child or adolescent.

The child's treating physician is responsible for determining or recommending that PDN services are medically necessary. If the state's expert disagrees with the treating physician as to whether a particular child's service is medically necessary, the state is responsible for the decision based on the medical documentation provided. The child or the child's family may appeal the state's decision under the Medi-Cal fair hearing procedures.

In the past, a “level of care analysis” and “cost limit” were used to decide requests for PDN services under EPSDT, but that is no longer the case. Coverage of EPSDT PDN services is determined based on medical necessity for each case.

Requesting EPSDT PDN if enrolled only in a managed care plan
For EPSDT to cover PDN services for a child or adolescent enrolled in a Medi-Cal managed care plan, the provider must request PDN by submitting a request to the managed care plan. Each managed care plan has its own procedures for requesting services. Providers should contact the child's managed care plan for that specific information.

Requesting EPSDT PDN through fee-for-service Medi-Cal
If a child or adolescent receives Medi-Cal services through fee-for-service Medi-Cal, the provider can request PDN services directly through the electronic Treatment Authorization Request (eTAR) system, and submit the necessary documentation by selecting “Submit Freeform Attachments.”

Requesting EPSDT PDN if related to a California Children's Services eligible condition
If the requested PDN services relate to a California Children's Services (CCS) eligible medical condition, the request must be directed to the EPSDT Unit. Eligibility is decided by CCS. If CCS denies the request on the grounds that the PDN services are not related to a CCS condition, the request can then be submitted to either the child's managed care plan or through fee-for-service to determine if the services are covered under EPSDT.

Each Treatment Authorization Request (TAR) for PDN services must include the following documents:

For general information about EPSDT services, providers can visit the Early and Periodic Screening, Diagnosis, and Treatment (EPSDT) Web page of the Department of Health Care Services (DHCS) website. The PDF document EPSDT – A Guide for States contains further information regarding EPSDT services, including but not limited to PDN.

Questions about coverage of PDN services under EPSDT can be directed to the DHCS Systems of Care Division, EPSDT Unit by phone at 1-855-347-9227 or by email at EPSDT@dhcs.ca.gov.

Print Article | Return to Top
 

16. Carbidopa and Levodopa Enteral Suspension is a New Medi-Cal Benefit

Effective for dates of service on or after January 1, 2017, HCPCS code J7340 (carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml) is a new Medi-Cal benefit.

The combination of carbidopa and levodopa is an enteral suspension used for the treatment of motor fluctuations in patients with advanced Parkinson's disease 18 years of age and older. Code J7340 must be billed with ICD-10-CM diagnosis code G20 (Parkinson's disease). A Treatment Authorization Request (TAR) is required for reimbursement.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Chronic Dialysis Clinics
Clinics and Hospitals
General Medicine
Obstetrics
Pharmacy
Rehabilitation Clinics
inject cd list (4); inject drug a-d (17, 18)
Print Article | Return to Top
 

17. Policy Update: ECMO/ECLS Age Groups

Effective retroactively for dates of service on or after January 1, 2015, Extracorporeal Membrane Oxygenation (ECMO)/Extracorporeal Life Support (ECLS) procedures will cover all ECMO/ECLS codes for all age groups (0 – 5 years of age and 6 – 99 years of age).

The following CPT-4 codes are Medi-Cal benefits for ECMO/ECLS procedures that will cover all age groups (0 – 5 years of age and 6 – 99 years of age):

CPT-4 Code Description
33946 Extracorporeal membrane oxygenation (ECMO)/extracorporeal life support (ECLS) provided by physician; initiation, veno-venous
33947 initiation, veno-arterial
33948 daily management, each day, veno-venous
33949 daily management, each day, veno-arterial
33951 insertion of peripheral cannula(e), percutaneous, birth through 5 years of age (includes fluoroscopic guidance, when performed)
33953 insertion of peripheral cannula(e), open, birth through 5 years of age
33955 insertion of peripheral cannula(e) by sternotomy or thoracotomy, birth through 5 years of age
33957 reposition of peripheral cannula(e), percutaneous, birth through 5 years of age (includes fluoroscopic guidance, when performed)
33959 reposition of peripheral cannula(e), open, birth through 5 years of age (includes fluoroscopic guidance, when performed)
33963 reposition of central cannula(e) by sternotomy or thoracotomy, birth through 5 years of age (includes fluoroscopic guidance, when performed)
33965 removal of peripheral cannula(e), percutaneous, birth through 5 years of age
33969 removal of peripheral cannula(e), open, birth through 5 years of age
33985 removal of central cannula(e) by sternotomy or thoracotomy, birth through 5 years of age
33987 Arterial exposure with creation of graft conduit (eg, chimney graft) to facilitate arterial perfusion for ECMO/ECLS
33988 Insertion of left heart vent by thoracic incision (eg, sternotomy, thoracotomy) for ECMO/ECLS
33989 Removal of left heart vent by thoracic incision (eg, sternotomy, thoracotomy) for ECMO/ECLS

In order to perform ECMO/ECLS for infants, the institution must be a California Children’s Services (CCS) approved Neonatal Intensive Care Unit (NICU) as both a regional NICU and an ECMO center. The institution must also be capable of providing inhaled nitric oxide services for neonates for children.

In order to perform ECMO for recipients awaiting lung transplantation, the institution must be a Medi-Cal approved Center of Excellence for lung transplantation and have performed ECMOs on adults for a minimum of three years and performed an average of five ECMOs per year.

Daily overall management of the recipient may be separately reported using the relevant hospital inpatient services or critical care evaluation and management codes (99218, 99219, 99220, 99221, 99222, 99223, 99231, 99232, 99233, 99234, 99235, 99236, 99291, 99292, 99468, 99469, 99471, 99472, 99475, 99476, 99477, 99478, 99479 and 99480) and may be reimbursed to any provider, same recipient and same date of service.

Services must be submitted on the claim with all revenue/sick baby codes applicable to the entire stay. An infant claim must be submitted for services rendered to the baby only. Care for the mother is billed separately.

The following are revenue codes for ECMO services provided to newborns, infants and children, and adults:

Revenue Code Description
174 Nursery, Newborn; Level IV (newborn 0-28 days)
202 Intensive Care, Medical (adults)
203 Intensive Care, Pediatric (infants and children)

An Erroneous Payment Correction (EPC) will be implemented to reprocess affected claims.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
Chronic Dialysis Clinics
Rehabilitation Clinics
modif used (11)
Clinics and Hospitals
General Medicine
medne (4–7); modif used (11); tar and non cd3 (5, 6)
Inpatient Services medne (4–7); tar and non cd3 (5, 6)
Obstetrics modif used (11); tar and non cd3 (5, 6)
Print Article | Return to Top
 

18. Modifier AS Updated in the Provider Manual

The November 2016 Medi-Cal Update announced that, effective retroactively for dates of service on or after January 1, 2012, certified nurse midwives (CNM) may be reimbursed as an “assistant at surgery” during cesarean section deliveries performed by a licensed physician and surgeon when billed with modifier AS. Billing information for modifier AS has been updated in the Modifiers: Approved List section of the Part 2 manual.

This information is reflected in the following provider manual(s):

Provider Manual(s) Page(s) Updated
AIDS Waiver Program
Audiology and Hearing Aids
Clinics and Hospitals
Chronic Dialysis Clinics
Durable Medical Equipment
Expanded Access to Primary Care Program
General Medicine
Home Health Agencies/Home and Community-Based Services
Local Educational Agency
Medical Transportation
Obstetrics
Orthotics and Prosthetics
Rehabilitation Clinics
Therapies
Vision Care
modif app (7, 22)
Print Article | Return to Top
 

19. National Correct Coding Initiative Quarterly Update for April 2017

The Centers for Medicare & Medicaid Services (CMS) has released the quarterly National Correct Coding Initiative (NCCI) payment policy updates. These mandatory national edits have been incorporated into the Medi-Cal claims processing system and are effective for dates of service on or after April 1, 2017.

For additional information, refer to The National Correct Coding Initiative in Medicaid page of the Medicaid website.

Print Article | Return to Top
 

20. May 2017 Medi-Cal Provider Seminar

The next Medi-Cal seminar is scheduled for May 23 – 24, 2017, at the Visalia Convention Center in Visalia, California. Providers can access a class schedule for the seminar by visiting the Provider Training Web page of the Medi-Cal Learning Portal (MLP) and clicking the seminar date(s) they would like to attend. Providers may RSVP by logging in to the MLP.

Throughout the year, the Department of Health Care Services (DHCS) and Conduent, the Fiscal Intermediary for Medi-Cal, conduct Medi-Cal training seminars. These seminars, which target both novice and experienced providers and billing staff, cover the following topics:

Providers must register by May 9, 2017, to receive a hard copy of the Medi-Cal provider training workbooks on the date(s) of training. After May 9, 2017, the workbooks will be available only by download on the Medi-Cal Provider Training Workbooks Web page of the Medi-Cal website.

Note:  Wi-Fi will not be provided at the seminar, please plan accordingly.

Providers that require more in-depth claim and billing information have the option to receive one-on-one claims assistance, which is available at all seminars, in the Claims Assistance Room.

Providers may also schedule a custom billing workshop. On the Lookup Regional Representative page, enter the ZIP code for the area you wish to search and click the “Enter ZIP Code” button. The name of the designated field representative for your area will appear on the map. To contact a regional representative, providers must first contact the Telephone Service Center (TSC) at 1-800-541-5555 and request to be contacted by a representative.

Providers are encouraged to bookmark the Provider Training Web page and refer to it often for current seminar information.

Print Article | Return to Top
 

21. Provider Manual Revisions

Pages updated due to ongoing provider manual revisions:

Print Article | Return to Top


Note:

If you cannot view the MS Word or PDF (Portable Document Format) documents correctly, please visit the Web Tool Box to link to a download site for the appropriate reader.